{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T05:27:20Z","timestamp":1794547640662,"version":"4.9.1"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300291"],"award-info":[{"award-number":["82300291"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019018","name":"Chinese Academy of Medical Sciences Initiative for Innovative Medicine","doi-asserted-by":"publisher","award":["2021-I2M-5-003"],"award-info":[{"award-number":["2021-I2M-5-003"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","award":["48014Y0243"],"award-info":[{"award-number":["48014Y0243"]}],"id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","award":["BYSYDL2023009"],"award-info":[{"award-number":["BYSYDL2023009"]}],"id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031233","name":"Michigan Medicine-PKUHSC Joint Institute for Translational and Clinical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031233","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005090","name":"Beijing Nova Program","doi-asserted-by":"publisher","award":["20230484275"],"award-info":[{"award-number":["20230484275"]}],"id":[{"id":"10.13039\/501100005090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008455","name":"Medical School, University of Michigan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008455","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017003","name":"Peking University Health Science Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009399","name":"Peking University Third Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.eclinm.2025.103462","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T08:31:31Z","timestamp":1756197091000},"page":"103462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Machine learning-based phenotyping and assessment of treatment responses in heart failure with preserved ejection fraction"],"prefix":"10.1016","volume":"88","author":[{"given":"Rui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conghui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2255-9748","authenticated-orcid":false,"given":"Wenyue","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-8207-678X","authenticated-orcid":false,"given":"Feng","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian E.","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel A.","family":"Beard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott L.","family":"Hummel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoxia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haihui","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0673-0058","authenticated-orcid":false,"given":"Xiaoyan","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinwei","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9712-803X","authenticated-orcid":false,"given":"Yi-Da","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10431","key":"10.1016\/j.eclinm.2025.103462_bib1","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0140-6736(23)02756-3","article-title":"Heart failure with preserved ejection fraction: everything the clinician needs to know","volume":"403","author":"Campbell","year":"2024","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.eclinm.2025.103462_bib2","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/jama.2023.2020","article-title":"Heart failure with preserved ejection fraction: a review","volume":"329","author":"Redfield","year":"2023","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103462_bib3","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan","year":"2006","journal-title":"N Engl J Med"},{"issue":"36","key":"10.1016\/j.eclinm.2025.103462_bib4","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103462_bib5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41572-024-00540-y","article-title":"Heart failure with preserved ejection fraction","volume":"10","author":"Hamo","year":"2024","journal-title":"Nat Rev Dis Primers"},{"issue":"18","key":"10.1016\/j.eclinm.2025.103462_bib6","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1016\/j.jacc.2023.01.049","article-title":"Heart failure with preserved ejection fraction","volume":"81","author":"Borlaug","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.eclinm.2025.103462_bib7","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1002\/ejhf.2654","article-title":"Clinical characteristics and 1-year outcomes in hospitalized patients with heart failure with preserved ejection fraction: results from the China Cardiovascular Association Database-Heart Failure Center Registry","volume":"24","author":"Cai","year":"2022","journal-title":"Eur J Heart Fail"},{"issue":"16","key":"10.1016\/j.eclinm.2025.103462_bib8","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.eclinm.2025.103462_bib9","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103462_bib10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1161\/CIRCULATIONAHA.124.072011","article-title":"Efficacy and safety of finerenone across the ejection fraction spectrum in heart failure with mildly reduced and preserved ejection fraction: a prespecified analysis of the FINEARTS-HF trial","volume":"151","author":"Docherty","year":"2025","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.eclinm.2025.103462_bib11","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1093\/eurheartj\/ehab911","article-title":"Heart failure with preserved ejection fraction in patients with normal natriuretic peptide levels is associated with increased morbidity and mortality","volume":"43","author":"Verbrugge","year":"2022","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103462_bib12","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s40292-020-00405-x","article-title":"Blood pressure, congestion and heart failure with preserved ejection fraction among patients with and without type 2 diabetes mellitus. A cluster analysis approach from the observational registry DICUMAP","volume":"27","author":"Ar\u00e9valo-Lorido","year":"2020","journal-title":"High Blood Press Cardiovasc Prev"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103462_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2459\/JCM.0000000000001116","article-title":"Phenotypic clustering of heart failure with preserved ejection fraction reveals different rates of hospitalization","volume":"22","author":"Casebeer","year":"2021","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"4","key":"10.1016\/j.eclinm.2025.103462_bib14","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1002\/ehf2.13969","article-title":"Phenotypes of heart failure with preserved ejection fraction and effect of spironolactone treatment","volume":"9","author":"Choy","year":"2022","journal-title":"ESC Heart Fail"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103462_bib15","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jchf.2019.09.009","article-title":"Clinical phenogroups in heart failure with preserved ejection fraction: detailed phenotypes, prognosis, and response to spironolactone","volume":"8","author":"Cohen","year":"2020","journal-title":"JACC Heart Fail"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103462_bib16","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1186\/s12916-022-02626-4","article-title":"Distinct implications of body mass index in different subgroups of nonobese patients with heart failure with preserved ejection fraction: a latent class analysis of data from the TOPCAT trial","volume":"20","author":"Dong","year":"2022","journal-title":"BMC Med"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103462_bib17","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/ehf2.13717","article-title":"Aetiological classification and prognosis in patients with heart failure with preserved ejection fraction","volume":"9","author":"Fayol","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.eclinm.2025.103462_bib18","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijcard.2020.08.065","article-title":"Characteristics, prognosis and treatment response in distinct phenogroups of heart failure with preserved ejection fraction","volume":"323","author":"Gu","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.eclinm.2025.103462_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2020.607760","article-title":"Different pathophysiology and outcomes of heart failure with preserved ejection fraction stratified by K-means clustering","volume":"7","author":"Harada","year":"2020","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103462_bib20","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1136\/heartjnl-2019-315481","article-title":"Identification of novel pheno-groups in heart failure with preserved ejection fraction using machine learning","volume":"106","author":"Hedman","year":"2020","journal-title":"Heart"},{"issue":"9","key":"10.1016\/j.eclinm.2025.103462_bib21","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/ejhf.327","article-title":"Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response","volume":"17","author":"Kao","year":"2015","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103462_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-46873-7","article-title":"Approaching higher dimension imaging data using cluster-based hierarchical modeling in patients with heart failure preserved ejection fraction","volume":"9","author":"Kobayashi","year":"2019","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103462_bib23","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1002\/ehf2.14368","article-title":"Heart failure with preserved ejection fraction phenogroup classification using machine learning","volume":"10","author":"Kyodo","year":"2023","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.eclinm.2025.103462_bib24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ahj.2022.08.009","article-title":"Machine learning to define phenotypes and outcomes of patients hospitalized for heart failure with preserved ejection fraction: findings from ASCEND-HF","volume":"254","author":"Murray","year":"2022","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.eclinm.2025.103462_bib25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3390\/bioengineering9040175","article-title":"Comparison of unsupervised machine learning approaches for cluster analysis to define subgroups of heart failure with preserved ejection fraction with different outcomes","volume":"9","author":"Nouraei","year":"2022","journal-title":"Bioengineering (Basel)"},{"key":"10.1016\/j.eclinm.2025.103462_bib26","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.ijcard.2021.01.052","article-title":"A new approach to the clinical subclassification of heart failure with preserved ejection fraction","volume":"331","author":"Nouraei","year":"2021","journal-title":"Int J Cardiol"},{"issue":"10","key":"10.1016\/j.eclinm.2025.103462_bib27","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/j.jcmg.2021.04.010","article-title":"Deep-learning models for the echocardiographic assessment of diastolic dysfunction","volume":"14","author":"Pandey","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103462_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0248317","article-title":"Unsupervised cluster analysis of patients with recovered left ventricular ejection fraction identifies unique clinical phenotypes","volume":"16","author":"Perry","year":"2021","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103462_bib29","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.echo.2018.12.002","article-title":"Contribution of cardiovascular reserve to prognostic categories of heart failure with preserved ejection fraction: a classification based on machine learning","volume":"32","author":"Przewlocka-Kosmala","year":"2019","journal-title":"J Am Soc Echocardiogr"},{"issue":"8","key":"10.1016\/j.eclinm.2025.103462_bib30","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006414","article-title":"Obese-inflammatory phenotypes in heart failure with preserved ejection fraction","volume":"13","author":"Sabbah","year":"2020","journal-title":"Circ Heart Fail"},{"issue":"6\u20137","key":"10.1016\/j.eclinm.2025.103462_bib31","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.acvd.2020.03.012","article-title":"Heart failure with preserved ejection fraction: a clustering approach to a heterogenous syndrome","volume":"113","author":"Schrub","year":"2020","journal-title":"Arch Cardiovasc Dis"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103462_bib32","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/ejhf.1621","article-title":"Phenomapping of patients with heart failure with preserved ejection fraction using machine learning-based unsupervised cluster analysis","volume":"22","author":"Segar","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103462_bib33","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/CIRCULATIONAHA.114.010637","article-title":"Phenomapping for novel classification of heart failure with preserved ejection fraction","volume":"131","author":"Shah","year":"2015","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.eclinm.2025.103462_bib34","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/heartjnl-2023-323059","article-title":"Pathophysiological insights into machine learning-based subphenotypes of acute heart failure with preserved ejection fraction","volume":"110","author":"Sotomi","year":"2024","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103462_bib35","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/1354750X.2020.1727015","article-title":"Enhanced clinical phenotyping by mechanistic bioprofiling in heart failure with preserved ejection fraction: insights from the MEDIA-DHF study (The Metabolic Road to Diastolic Heart Failure)","volume":"25","author":"Stienen","year":"2020","journal-title":"Biomarkers"},{"issue":"6","key":"10.1016\/j.eclinm.2025.103462_bib36","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/ejhf.2169","article-title":"Identification of distinct phenotypic clusters in heart failure with preserved ejection fraction","volume":"23","author":"Uijl","year":"2021","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"10.1016\/j.eclinm.2025.103462_bib37","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/ejhf.2144","article-title":"Machine learning based on biomarker profiles identifies distinct subgroups of heart failure with preserved ejection fraction","volume":"23","author":"Woolley","year":"2021","journal-title":"Eur J Heart Fail"},{"issue":"22","key":"10.1016\/j.eclinm.2025.103462_bib38","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1113\/JP281845","article-title":"Phenotyping heart failure using model-based analysis and physiology-informed machine learning","volume":"599","author":"Jones","year":"2021","journal-title":"J Physiol"},{"issue":"37","key":"10.1016\/j.eclinm.2025.103462_bib39","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"issue":"15","key":"10.1016\/j.eclinm.2025.103462_bib40","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction","volume":"370","author":"Pitt","year":"2014","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103462_bib41","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCULATIONAHA.114.013255","article-title":"Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial","volume":"131","author":"Pfeffer","year":"2015","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103462_bib42","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/s41746-025-01501-9","article-title":"Identification of digital twins to guide interpretable AI for diagnosis and prognosis in heart failure","volume":"8","author":"Gu","year":"2025","journal-title":"NPJ Digit Med"},{"key":"10.1016\/j.eclinm.2025.103462_bib43","article-title":"Fengshenbang 1.0: being the foundation of Chinese cognitive intelligence","author":"Zhang","year":"2022","journal-title":"arXiv"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103462_bib44","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/mpr.329","article-title":"Multiple imputation by chained equations: what is it and how does it work?","volume":"20","author":"Azur","year":"2011","journal-title":"Int J Methods Psychiatr Res"},{"key":"10.1016\/j.eclinm.2025.103462_bib45","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0377-0427(87)90125-7","article-title":"Silhouettes: a graphical aid to the interpretation and validation of cluster analysis","volume":"20","author":"Rousseeuw","year":"1987","journal-title":"J Comput Appl Math"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103462_bib46","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/1467-9868.00293","article-title":"Estimating the number of clusters in a data set via the gap statistic","volume":"63","author":"Tibshirani","year":"2002","journal-title":"J Roy Stat Soc B Stat Methodol"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103462_bib47","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/01969727408546059","article-title":"Well-separated clusters and optimal fuzzy partitions","volume":"4","author":"Dunn","year":"1974","journal-title":"J Cybern"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103462_bib48","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1109\/TIT.1982.1056489","article-title":"Least squares quantization in PCM","volume":"28","author":"Lloyd","year":"1982","journal-title":"IEEE Trans Inf Theor"},{"key":"10.1016\/j.eclinm.2025.103462_bib49","series-title":"Deepcluster: A General Clustering Framework Based on Deep Learning","first-page":"809","author":"Tian","year":"2017"},{"key":"10.1016\/j.eclinm.2025.103462_bib50","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF01908075","article-title":"Comparing partitions","volume":"2","author":"Hubert","year":"1985","journal-title":"J Classif"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103462_bib51","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","article-title":"Interrater reliability: the kappa statistic","volume":"22","author":"McHugh","year":"2012","journal-title":"Biochem Med (Zagreb)"},{"issue":"20","key":"10.1016\/j.eclinm.2025.103462_bib52","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.009594","article-title":"Meta-Analysis Global Group in Chronic (MAGGIC) heart failure risk score: validation of a simple tool for the prediction of morbidity and mortality in heart failure with preserved ejection fraction","volume":"7","author":"Rich","year":"2018","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103462_bib53","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa2030186","article-title":"Sotagliflozin in patients with diabetes and chronic kidney disease","volume":"384","author":"Bhatt","year":"2021","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.eclinm.2025.103462_bib54","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1053\/j.ajkd.2021.05.005","article-title":"Canagliflozin and kidney-related adverse events in type 2 diabetes and CKD: findings from the randomized CREDENCE trial","volume":"79","author":"Heerspink","year":"2022","journal-title":"Am J Kidney Dis"},{"issue":"15","key":"10.1016\/j.eclinm.2025.103462_bib55","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.eclinm.2025.103462_bib56","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1007\/s11255-021-03025-z","article-title":"Efficacy of medication therapy for patients with chronic kidney disease and heart failure with preserved ejection fraction: a systematic review and meta-analysis","volume":"54","author":"Yang","year":"2022","journal-title":"Int Urol Nephrol"},{"issue":"19","key":"10.1016\/j.eclinm.2025.103462_bib57","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1001\/jama.2021.18463","article-title":"Effect of sacubitril\/valsartan vs standard medical therapies on plasma NT-proBNP concentration and submaximal exercise capacity in patients with heart failure and preserved ejection fraction: the PARALLAX randomized clinical trial","volume":"326","author":"Pieske","year":"2021","journal-title":"JAMA"},{"issue":"9851","key":"10.1016\/j.eclinm.2025.103462_bib58","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/S0140-6736(12)61227-6","article-title":"The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial","volume":"380","author":"Solomon","year":"2012","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/j.eclinm.2025.103462_bib59","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction","volume":"381","author":"Solomon","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.eclinm.2025.103462_bib60","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/s12933-022-01545-1","article-title":"Effects of sacubitril\/valsartan on glycemia in patients with diabetes and heart failure: the PARAGON-HF and PARADIGM-HF trials","volume":"21","author":"Wijkman","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.eclinm.2025.103462_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173444","article-title":"Effects of sacubitril\/valsartan in patients with heart failure and chronic kidney disease: a meta-analysis","volume":"884","author":"Kang","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.eclinm.2025.103462_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175053","article-title":"Effect of sacubitril\/valsartan on renal function in patients with chronic kidney disease and heart failure with preserved ejection fraction: a real-world 12-week study","volume":"928","author":"Jia","year":"2022","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"10.1016\/j.eclinm.2025.103462_bib63","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1161\/CIRCULATIONAHA.119.044586","article-title":"Sacubitril\/valsartan across the spectrum of ejection fraction in heart failure","volume":"141","author":"Solomon","year":"2020","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.eclinm.2025.103462_bib64","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1161\/CIRCHEARTFAILURE.114.001301","article-title":"Calcium channel blockers and outcomes in older patients with heart failure and preserved ejection fraction","volume":"7","author":"Patel","year":"2014","journal-title":"Circ Heart Fail"},{"issue":"3","key":"10.1016\/j.eclinm.2025.103462_bib65","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ijcard.2013.12.008","article-title":"Prognostic factors of heart failure with preserved ejection fraction: a 12-year prospective cohort follow-up study","volume":"171","author":"Wu","year":"2014","journal-title":"Int J Cardiol"},{"issue":"9","key":"10.1016\/j.eclinm.2025.103462_bib66","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/eurjpc\/zwac004","article-title":"Associations between calcium channel blocker therapy and mortality in heart failure with preserved ejection fraction","volume":"29","author":"Wang","year":"2022","journal-title":"Eur J Prev Cardiol"},{"issue":"17","key":"10.1016\/j.eclinm.2025.103462_bib67","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1161\/CIRCULATIONAHA.114.013709","article-title":"Rate-control treatment and mortality in atrial fibrillation","volume":"132","author":"Chao","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.eclinm.2025.103462_bib68","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.amjcard.2023.04.013","article-title":"Association of nondihydropyridine calcium channel blockers versus \u03b2-adrenergic receptor blockers with risk of heart failure hospitalization","volume":"197","author":"Meyer","year":"2023","journal-title":"Am J Cardiol"},{"issue":"18","key":"10.1016\/j.eclinm.2025.103462_bib69","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537025003943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537025003943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T05:07:23Z","timestamp":1794546443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537025003943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":69,"alternative-id":["S2589537025003943"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103462","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Machine learning-based phenotyping and assessment of treatment responses in heart failure with preserved ejection fraction","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2025.103462","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103462"}}